1Cademy - Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination

Learn Before

Methods for determining odds of abnormal ECG readings amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Methods for determining hazard ratio for in-hospital mortality amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Methods for determining odds of cardiac arrest amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination

Concept

Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination

Patient demographics
Preexisting conditions
Initial vital signs
Laboratory test results within 24 hours of admission
Chest imaging
Racial and ethnic classification

0

1

Updated 2020-05-25

Contributors are:

Who are from:

University of Michigan - Ann Arbor

🏆 3

References

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Learn Before

Related